Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Current Assets (2016 - 2024)

Historic Current Assets for Sanofi (SNY) over the last 17 years, with Q3 2025 value amounting to $39.8 billion.

  • Sanofi's Current Assets changed N/A to $39.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $39.8 billion, marking a year-over-year change of. This contributed to the annual value of $45.5 billion for FY2024, which is 3717.43% up from last year.
  • Latest data reveals that Sanofi reported Current Assets of $39.8 billion as of Q3 2025.
  • In the past 5 years, Sanofi's Current Assets ranged from a high of $46.3 billion in Q1 2025 and a low of $30.3 billion during Q2 2022
  • Its 5-year average for Current Assets is $37.0 billion, with a median of $35.0 billion in 2021.
  • Per our database at Business Quant, Sanofi's Current Assets surged by 288143.19% in 2021 and then crashed by 1482.39% in 2022.
  • Over the past 5 years, Sanofi's Current Assets (Quarter) stood at $35.0 billion in 2021, then decreased by 0.47% to $34.8 billion in 2022, then fell by 5.18% to $33.0 billion in 2023, then surged by 37.91% to $45.5 billion in 2024, then fell by 12.55% to $39.8 billion in 2025.
  • Its Current Assets stands at $39.8 billion for Q3 2025, versus $41.9 billion for Q2 2025 and $46.3 billion for Q1 2025.